258 related articles for article (PubMed ID: 30382763)
41. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
[TBL] [Abstract][Full Text] [Related]
43. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway.
Zhang LQ; Cui H; Yu YB; Shi HQ; Zhou Y; Liu MJ
J Cell Physiol; 2019 Jun; 234(6):8873-8887. PubMed ID: 30515784
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
47. RanBPM is an inhibitor of ERK signaling.
Atabakhsh E; Schild-Poulter C
PLoS One; 2012; 7(10):e47803. PubMed ID: 23118896
[TBL] [Abstract][Full Text] [Related]
48. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways.
Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS
PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276
[TBL] [Abstract][Full Text] [Related]
50. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway.
Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
52. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
54. Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.
Hsiao YC; Yeh MH; Chen YJ; Liu JF; Tang CH; Huang WC
Oncotarget; 2015 Nov; 6(35):37965-78. PubMed ID: 26513016
[TBL] [Abstract][Full Text] [Related]
55. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
Wang DW; Wang YQ; Shu HS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
[TBL] [Abstract][Full Text] [Related]
56. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells.
Subramanian RR; Yamakawa A
Int J Oncol; 2012 Nov; 41(5):1855-62. PubMed ID: 22922669
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
58. C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
Jilaveanu LB; Zito CR; Aziz SA; Conrad PJ; Schmitz JC; Sznol M; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2009 Sep; 15(18):5704-13. PubMed ID: 19737955
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.
Hong L; Wang Y; Chen W; Yang S
J Cell Biochem; 2018 Sep; 119(9):7431-7440. PubMed ID: 29781537
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of microRNA-216a confers protection against yttrium aluminium garnet laser-induced retinal injury
Hu XB; Fu SH; Luo QI; He JZ; Qiu YF; Lai W; Zhong M
J Biosci; 2018 Dec; 43(5):985-1000. PubMed ID: 30541958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
